| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/18/2010 | CA2422367C Pyrazole compounds useful as protein kinase inhibitors |
| 05/18/2010 | CA2304204C Quinoline-containing .alpha.-ketoamide cysteine and serine protease inhibitors |
| 05/18/2010 | CA2284041C Indolecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
| 05/18/2010 | CA2259143C G-beta-gamma regulated phosphatidylinositol-3' kinase p101 regulatory subunit |
| 05/18/2010 | CA2131797C Condensed indole derivatives as 5ht4-receptor antagonists |
| 05/18/2010 | CA2121698C Synthesis of human procollagens and collagens in recombinant dna systems |
| 05/14/2010 | WO2010054316A2 Endothelium mimicking nanomatrix |
| 05/14/2010 | WO2010054229A1 Quinoxaline-based lxr modulators |
| 05/14/2010 | WO2010054126A2 Small molecule modulators of epigenetic regulation and their therapeutic applications |
| 05/14/2010 | WO2010054114A2 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors |
| 05/14/2010 | WO2010054113A2 Cycloalkane[b]azaindole antagonists of prostaglandin d2 receptors |
| 05/14/2010 | WO2010054024A2 Novel compounds as cannabinoid receptor ligands |
| 05/14/2010 | WO2010054015A2 Methods of reducing the risk of cardiovascular disease in postmenopausal women |
| 05/14/2010 | WO2010054001A2 D-tagatose-based compositions and methods for preventing and treating atherosclerosis, metabolic syndrome, and symptoms thereof |
| 05/14/2010 | WO2010053829A1 Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders |
| 05/14/2010 | WO2010053757A1 2 -oxoquinoxalin blockers of the late sodium channel |
| 05/14/2010 | WO2010053456A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction |
| 05/14/2010 | WO2010053430A1 Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells |
| 05/14/2010 | WO2010053233A1 The new telmisartan zinc salt and the preparation thereof |
| 05/14/2010 | WO2010052993A1 Anthracene derivative cycloadded with acylnitroso derivative, and light-activated hno donor |
| 05/14/2010 | WO2010052828A1 Pharmaceutical agent for nonischemic myocardial disorders |
| 05/14/2010 | WO2010015652A3 Thiazole compounds as medicaments for the treatment of (inter alia) cardiovascular diseases |
| 05/14/2010 | WO2010014199A3 Uses of morelloflavone |
| 05/14/2010 | WO2010011868A3 Pyridine sulfonamide modulators of endothelin-a-receptor |
| 05/14/2010 | WO2010008244A3 Pharmaceutical preparation |
| 05/14/2010 | WO2010006184A3 Small-molecule inhibitors of hif and angiogenesis |
| 05/14/2010 | WO2009050580A8 Composition for regulating lipid metabolism |
| 05/14/2010 | CA2778938A1 Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells |
| 05/14/2010 | CA2746054A1 Small molecule modulators of epigenetic regulation and their therapeutic applications |
| 05/14/2010 | CA2742782A1 Endothelium mimicking nanomatrix |
| 05/14/2010 | CA2741537A1 Quinoxaline-based lxr modulators |
| 05/14/2010 | CA2741047A1 Novel compounds as cannabinoid receptor ligands |
| 05/13/2010 | US20100120921 Renin inhibitors for treatment of hypertension in patients with high sodium diet |
| 05/13/2010 | US20100120919 Methods for treating transthyretin amyloid diseases |
| 05/13/2010 | US20100120912 Esters of capsaicinoids as dietary supplements |
| 05/13/2010 | US20100120909 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 05/13/2010 | US20100120890 Ion channel modulating activity i |
| 05/13/2010 | US20100120877 Additional therapeutic use |
| 05/13/2010 | US20100120875 Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis |
| 05/13/2010 | US20100120864 2-aminooxazolines as taar1 ligands |
| 05/13/2010 | US20100120859 Novel case of renin inhibitors |
| 05/13/2010 | US20100120849 Compositions for Treating Hyperproliferative Vascular Disorders and Cancers |
| 05/13/2010 | US20100120839 Pyrazoles useful in the treatment of inflammation |
| 05/13/2010 | US20100120810 Compounds and methods for modulating rho gtpases |
| 05/13/2010 | US20100120808 Spirocyclic heterocyclic derivatives and methods of their use |
| 05/13/2010 | US20100120807 Compounds and compositions as modulators of gpr119 activity |
| 05/13/2010 | US20100120804 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 05/13/2010 | US20100120803 3,4-dihydroquinazoline derivatives |
| 05/13/2010 | US20100120800 Agent for preventing recurrence of cerebrovascular disorder and agent for ameliorating troubles following cerebrovascular disorder and inhibiting progress thereof |
| 05/13/2010 | US20100120798 Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety |
| 05/13/2010 | US20100120794 Cycloalkylamino Acid Derivatives |
| 05/13/2010 | US20100120792 Substituted 2,3,4,5-Tetrahyrdo-1H-Pyrido[4,3-B]Indoles, Methods for the Production and Use Thereof |
| 05/13/2010 | US20100120784 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 05/13/2010 | US20100120778 Quinoxaline-based lxr modulators |
| 05/13/2010 | US20100120762 Triazine derivatives as inhibitors of phosphodiesterases |
| 05/13/2010 | US20100120749 Tetrahydroindole derivatives as nadph oxidase inhibitors |
| 05/13/2010 | US20100120745 Anti-angiogenic agents and methods of use |
| 05/13/2010 | US20100120731 3-([1,2,4]triazolo [4,3-a]pyridin-7-yl)benzamide derivatives |
| 05/13/2010 | US20100120730 6-benzyl-2,3,4,7-tetrahydro-indolo [2,3-c] quinoline compounds useful as pde5 inhibitors |
| 05/13/2010 | US20100120726 1-Methylnicotinamide Derivatives and Formulations of Treatment of Lipoprotein Abnormalities |
| 05/13/2010 | US20100120718 Combination therapy of substituted oxazolidinones |
| 05/13/2010 | US20100120710 Branched alpha-glucan, alpha-glucosyltransferase which forms the glucan, their preparation and uses |
| 05/13/2010 | US20100120705 Compositions and products containing s-equol, and methods for their making |
| 05/13/2010 | US20100120704 Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders |
| 05/13/2010 | US20100120694 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 05/13/2010 | US20100120693 Medicament for improving prognostic survival in therapy of malignant tumor |
| 05/13/2010 | US20100120692 Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration |
| 05/13/2010 | US20100120670 Cyclised alpha-conotoxin peptides |
| 05/13/2010 | US20100120669 Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase |
| 05/13/2010 | US20100120665 Treatment of diseases characterized by inflammation |
| 05/13/2010 | US20100120660 Highly concentrated insulin solutions and compositions |
| 05/13/2010 | US20100120015 Method of collecting placental stem cells |
| 05/13/2010 | US20100119694 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 05/13/2010 | US20100119629 Angina pectoris and ischemic heart disease and synergistic phytoceutical composition for same |
| 05/13/2010 | US20100119605 Compositions for tissue stabilization |
| 05/13/2010 | US20100119580 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 05/13/2010 | US20100119576 Use of one or more of the elements from the group yttrium, neodymium and zirconium, and pharmaceutical compositions which contain those elements |
| 05/13/2010 | US20100119574 Recombinant Gelatins |
| 05/13/2010 | US20100119573 Endothelium mimicking nanomatrix |
| 05/13/2010 | US20100119572 Polyvinyl alcohol microspheres, injectable solutions and therapeutic uses of the same |
| 05/13/2010 | US20100119555 Methods and Compositions for the Treatment and Diagnosis of Cancer |
| 05/13/2010 | US20100119541 Use of a vegetable drug composition in the manufacturing of pharmaceutical preparation for the treatment of portal hypertension caused by hepatocirrhosis |
| 05/13/2010 | US20100119529 Elastin-like polymer delivery vehicles |
| 05/13/2010 | US20100119526 DLL4 Signaling Inhibitors and Uses Thereof |
| 05/13/2010 | US20100119510 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 05/13/2010 | US20100119503 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 05/13/2010 | US20100119478 ANTIBODIES DIRECTED AGAINST PYROGLUTAMATE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1 N1pE) |
| 05/13/2010 | US20100119476 Selection of peptides specific for human blood outgrowth endothelial cells |
| 05/12/2010 | EP2184284A1 Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as the active ingredient |
| 05/12/2010 | EP2184282A1 Novel salt of isoquinoline compound and crystal thereof |
| 05/12/2010 | EP2184277A1 Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof |
| 05/12/2010 | EP2184272A1 Piperazine derivative |
| 05/12/2010 | EP2184063A1 The use of leonurine and compositions thereof |
| 05/12/2010 | EP2183254A1 Inhibitors of protein tyrosine kinase activity |
| 05/12/2010 | EP2183223A2 Metabolites and derivatives of ambrisentan |
| 05/12/2010 | EP2183214A1 Crystalline teglicar |
| 05/12/2010 | EP2183028A2 Targeted binging agents directed to kdr and uses thereof - 035 |
| 05/12/2010 | EP2182965A1 Extracts of ligustrum lucidum and uses thereof |
| 05/12/2010 | EP2182954A1 Use of nor-bile acids in the treatment of arteriosclerosis |
| 05/12/2010 | EP2182935A1 The use of benzamide derivatives for the treatment of cns disorders |